Literature DB >> 20538907

The human immunodeficiency virus type 1 Rev protein: ménage à trois during the early phase of the lentiviral replication cycle.

Bastian Grewe1, Klaus Überla1.   

Abstract

The Rev protein of human immunodeficiency viruses (HIV) has long been recognized to be essential for the late phase of the virus replication cycle, due to its strong enhancement of expression of viral structural proteins. Surprisingly, a number of recent papers have demonstrated that Rev can also interfere with integration of the reverse-transcribed cDNA into the host-cell genome. This seems to be due to Rev's binding to integrase and LEDGF/p75, an important cellular cofactor of HIV-1 integration. As Rev is presumably expressed at sufficiently high levels only after the encoding genome has already integrated, the main function of Rev during the early phase might be to reduce genotoxicity due to excessive integration events after superinfection of the same cell by subsequent viruses. Other potential consequences for HIV-1 replication and evolution after co-infection of the same cell with two viruses are discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20538907     DOI: 10.1099/vir.0.022509-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

Review 1.  Insights into cellular factors that regulate HIV-1 replication in human cells.

Authors:  Andrew M L Lever; Kuan-Teh Jeang
Journal:  Biochemistry       Date:  2011-01-24       Impact factor: 3.162

2.  Generation and use of antibody fragments for structural studies of proteins refractory to crystallization.

Authors:  Stephen J Stahl; Norman R Watts; Paul T Wingfield
Journal:  Methods Mol Biol       Date:  2014

3.  Integrase-derived peptides together with CD24-targeted lentiviral particles inhibit the growth of CD24 expressing cancer cells.

Authors:  Shiran Shapira; Eynat Finkelshtein; Dina Kazanov; Esmira Naftali; Irena Stepansky; Abraham Loyter; Daniel Elbirt; Mori Hay-Levy; Eli Brazowski; Faina Bedny; Roy Dekel; Dov Hershkovitz; Arye Blachar; Ido Wolf; Nadir Arber
Journal:  Oncogene       Date:  2021-05-06       Impact factor: 9.867

4.  Formation of trans-activation competent HIV-1 Rev:RRE complexes requires the recruitment of multiple protein activation domains.

Authors:  Dirk Hoffmann; Doreen Schwarck; Carina Banning; Matthias Brenner; Lakshmikanth Mariyanna; Marcel Krepstakies; Michael Schindler; David P Millar; Joachim Hauber
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

5.  Inhibiting the HIV integration process: past, present, and the future.

Authors:  Roberto Di Santo
Journal:  J Med Chem       Date:  2013-09-25       Impact factor: 7.446

6.  The HIV 5' Gag Region Displays a Specific Nucleotide Bias Regulating Viral Splicing and Infectivity.

Authors:  Bastian Grewe; Carolin Vogt; Theresa Horstkötter; Bettina Tippler; Han Xiao; Bianca Müller; Klaus Überla; Ralf Wagner; Benedikt Asbach; Jens Bohne
Journal:  Viruses       Date:  2021-05-27       Impact factor: 5.048

7.  Dynamic Post-Transcriptional Regulation of HIV-1 Gene Expression.

Authors:  Anna Kula; Alessandro Marcello
Journal:  Biology (Basel)       Date:  2012-07-03

8.  A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1.

Authors:  Min-Hsuan Lin; Haran Sivakumaran; Alun Jones; Dongsheng Li; Callista Harper; Ting Wei; Hongping Jin; Lina Rustanti; Frederic A Meunier; Kirsten Spann; David Harrich
Journal:  Retrovirology       Date:  2014-12-14       Impact factor: 4.602

Review 9.  Review of Current Cell-Penetrating Antibody Developments for HIV-1 Therapy.

Authors:  Muhamad Alif Che Nordin; Sin-Yeang Teow
Journal:  Molecules       Date:  2018-02-06       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.